[2P] Poster Presentation 2

[2P-723] The feasibility of genome editing-mediated gene-silencing therapy for DRPLA

○Taisuke Kato¹, Sho Kitahara², Yuka Mitsuhashi², Kobayashi Kenta³, Onodera Osamu² (1. Department of Molecular Neuroscience, Brain Research Institute, Niigata University, 2. Department of Neurology, Brain Research Institute, Niigata University, 3. Department of Viral Vector Development, National Institute for Physiological Science)